Back to top

Dianthus (DNTH) Price Target Raised by Guggenheim Ahead of Key Trial

Dianthus (DNTH) Price Target Raised by Guggenheim Ahead of Key Trial

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Dianthus Therapeutics, Inc. (DNTH)